Citations

Showing 10 of 108152 citations.

Intratumoral CD3+ and CD8+ T-Cell Densities in Patients With DNA Mismatch Repair–Deficient Metastatic Colorectal Cancer Receiving Programmed Cell Death-1 Blockade
Chakrabarti, Sakti , Huebner, Lucas J. , Finnes, Heidi D. , Murányi, Andrea , Clements, June, Singh, Shalini , Shanmugam, Kandavel , Hubbard, Joleen M. , McWilliams, Robert R. , Chakrabarti, Sakti , Sinicrope, Frank A.

Mayo Clinic

JCO Precision Oncology | June 27, 2019 | Volume: No volume available | Issue: 3 | Pages: 1-7

10.1200/po.19.00055 | PMID 35100708 Get It

Impact of acquired del(17p) in multiple myeloma
Lakshman, Arjun , Painuly, Utkarsh , Rajkumar, S. Vincent , Kapoor, Prashant , Greipp, Patricia T. , Gertz, Morie A. , Buadi, Francis K. , Lacy, Martha Q. , Dingli, David , Fonder, Amie , Hayman, Suzanne R. , Hobbs, Miriam, Hwa, Yi L. , Lin, Yi , Kourelis, Taxiarchis , Warsame, Rahma , Lust, John A., Russell, Stephen J. , Zeldenrust, Steven R., Kyle, Robert A. , Kumar, Shaji , Dispenzieri, Angela , Gertz, Morie A , Buadi, Francis K , Lacy, Martha Q , Fonder, Amie L, Hwa, Yi Lisa, Leung, Nelson , Kourelis, Taxiarchis V, Warsame, Rahma , Russell, Stephen J , Kumar, Shaji K , Rajkumar, S Vincent , Lakshman, Arjun , Dingli, David , Greipp, Patricia T , Lin, Yi , Ketterling, Rhett P. , Dispenzieri, Angela , Gonsalves, Wilson I. , Leung, Nelson , Go, Ronald S.

Mayo Clinic

Blood Advances | June 27, 2019 | Volume: 3 | Issue: 13 | Pages: 1930-1938

10.1182/bloodadvances.2018028530 | PMID 31248884 Get It

Abstract The high-risk abnormality del(17p) can be detected by fluorescence in situ hybridization on malignant plasma cells (PCs) and has an adverse prognostic impact in patients with multiple myeloma (MM). Patients with del(17p) have reduced overall survival (OS). Patients who acquire del(17p) later during the disease course are not well described. The disease characteristics at diagnosis predicting for acquired del(17p) and its overall impact on patient survival is not known. We compared 76 patients with MM who were negative for del(17p) at diagnosis and acquired it later with 152 control MM patients who did not acquire del(17p) at a comparable time point. Patients acquired del(17p) at a median of 35.6 months (range, 4.6-116.1 months) from diagnosis of MM after a median of 2 lines of therapy (range, 1-10 lines of therapy). When compared with controls, patients with acquired del(17p) had shorter median progression-free survival (PFS) (30.1 vs 23.0 months; P = .032) and OS (106.1 vs 68.2 months; P < .001) from diagnosis. After the detection of del(17p), the median PFS was 5.4 months and the median OS was 18.1 months. High lactate dehydrogenase level (odds ratio [OR], 3.69; 95% confidence interval [CI], 1.11-12.24) and presence of t(4;14) (OR, 2.66; 95% CI, 1.09-6.48) or any high-risk translocation (OR, 2.23; 95% CI, 1.00-4.95) at diagnosis predicted acquisition of del(17p). High PC proliferative rate predicted shorter OS from detection of del(17p) (hazard ratio, 2.28; 95% CI, 1.31-3.96; P = .004). Our study shows that acquisition of del(17p) is an important molecular event associated with reduction in OS in MM. Certain baseline factors may predict acquisition of del(17p). This needs validation in prospective data sets.
Eliminating Postoperative Radiation to the Pathologically Node-Negative Neck: Long-Term Results of a Prospective Phase II Study
Contreras, J. , Spencer, Christopher , DeWees, T.A. , Haughey, Bruce H. , Henke, Lauren E. , Chin, R , Paniello, Randal C., Rich, Jason T. , Jackson, Ryan S. , Oppelt, Peter , Pipkorn, Patrik , Zevallos, José P. , Daly, Mackenzie, DeWees, Todd, DeWees, Todd A , Spencer, Christopher, Oppelt, Peter, Chernock, Rebecca , Nussenbaum, Brian A. , Gay, Hiram A. , Adkins, Douglas R. , Thorstad, Wade

Mayo Clinic

Journal of Clinical Oncology | June 27, 2019 | Volume: 37 | Issue: 28 | Pages: 2548-2555

10.1200/jco.19.00186 | PMID 31246526 Get It

PURPOSE The volume treated with postoperative radiation therapy (PORT) is a mediator of toxicity, and reduced volumes result in improved quality of life (QOL). In this phase II trial, treatment volumes were reduced by omitting PORT to the pathologically negative (PN0) neck in patients with primary head and neck squamous cell carcinoma. METHODS Patients with head and neck squamous cell carcinoma who underwent surgical resection and neck dissection with a PN0 neck and high-risk features mandating PORT to the primary and/or involved neck were eligible. The primary end point was greater than 90% disease control in the unirradiated neck. QOL was evaluated using the MD Anderson Dysphagia Inventory and the University of Michigan patient-reported xerostomia questionnaire. RESULTS Seventy-three patients were enrolled, and 72 were evaluable. Median age was 56 years (range, 31 to 81 years); 58 patients were male, and 47 (65%) had a smoking history. Sites included oral cavity (n = 14), oropharynx (n = 37), hypopharynx (n = 4), larynx (n = 16), and unknown primary tumor (n = 1). According to the American Joint Committee on Cancer Staging Manual (7 th edition), 67 patients (93%) had stage III/IV disease, and 71% of tumors involved or crossed midline. No patient had contralateral neck PORT. In 17 patients (24%), only the primary site was treated. At a median follow-up of 53 months, two patients experienced treatment failure of the PN0 unirradiated neck; they also experienced treatment failure locally. Unirradiated neck control was 97% (95% CI, 93.4% to 100.0%). Five-year rates of local control, regional control, progression-free survival, and overall survival were 84%, 93%, 60%, and 64%, respectively. QOL measures were not significantly different from baseline at 12 and 24 months post-PORT ( P > .05). CONCLUSION Eliminating PORT to the PN0 neck resulted in excellent control rates in the unirradiated neck without long-term adverse effects on global QOL.
The rabbit brachial plexus as a model for nerve injury and repair Part 1: Anatomic study of the biceps and triceps innervation
Kollitz, Kathleen M. , Giusti, Guilherme , Friedrich, Patricia F. , Shin, Alexander Y. , Shin, Alexander Y , Bishop, Allen T.

Mayo Clinic

Microsurgery | June 27, 2019 | Volume: 40 | Issue: 2 | Pages: 183-188

10.1002/micr.30482 | PMID 31246325 Get It

AbstractPurposeAnimal models can be helpful in evaluating new surgical strategies for brachial plexus reconstruction. While several groups have already used the rabbit brachial plexus to model injury, reports conflict in anatomic detail and do not identify a nerve‐muscle pair to measure motor function recovery after reconstruction. The purpose of the current study is to describe the innervations of the biceps and triceps muscles in rabbits, which are both amenable to study in brachial plexus injury models.Materials and MethodsThirteen rabbits weighing 2–2.5 kg were anesthetized. Six rabbits were sacrificed and dissected using loupe and microscope magnification to understand the overall morphology of the brachial plexus. Seven rabbits underwent electrophysiologic investigation. A bipolar nerve stimulator was used to systematically stimulate the roots, trunks and divisions, and nerve branches of the rabbit brachial plexus and compound muscle action potential was used to record muscle response. Nerve length and width measurements were not recorded.ResultsRoots contributing to the brachial plexus were C5, C6, C7, C8, and T1. In contrast to other anatomical studies, T2 did not contribute to the brachial plexus. The triceps was innervated by the radial nerve, which received contributions from C6 (1.6 mA), C7 (1.9 mA), C8, and T1 (12.2 mA).The biceps had dual innervation (proximally and distally). The proximal branch received contributions from C6 (3.5 mA) and C7 (5mA). The distal portion was innervated by a branch from the median nerve, which received innervation from C6, C7, C8, and T1.ConclusionsThe overall structure of rabbit brachial plexus is described and innervation of the biceps and triceps is described in detail. This anatomic investigation will form the basis of a future brachial plexus model of injury and repair.
Phenotypic heterogeneity associated with germline GATA2 haploinsufficiency: a comprehensive kindred study
Haddox, Candace L. , Carr, Ryan M. , Abraham, Roshini S. , Botero, Juliana Perez , Rodriguez, Vilmarie , Pardanani, Animesh , Patnaik, Mrinal M. , Perez Botero, Juliana , Haddox, Candace L , Carr, Ryan M

Mayo Clinic

Leukemia & Lymphoma | June 27, 2019 | Volume: 60 | Issue: 13 | Pages: 3282-3286

10.1080/10428194.2019.1633630 | PMID 31246134 Get It

Clinicopathologic correlations in a family with aTBK1mutation presenting as primary progressive aphasia and primary lateral sclerosis
Hirsch‐Reinshagen, Veronica , Alfaify, Omar A., Hsiung, Ging‐Yuek Robin , Pottier, Cyril , Baker, Matt , Perkerson, Ralph B., Rademakers, Rosa , Briemberg, Hanna, Foti, Dean, Mackenzie, Ian R. , Hsiung, Gink-Yuek , Pottier, Cyril , Briemberg, Hannah

Mayo Clinic

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | June 27, 2019 | Volume: 20 | Issue: 7-8 | Pages: 568-575

10.1080/21678421.2019.1632347 | PMID 31244341 Get It

Diarrhoea: interventions, consequences and epidemiology in the intensive care unit (DICE-ICU): a protocol for a prospective multicentre cohort study
Dionne, Joanna C. , Sullivan, Kristen , Takaoka, Alyson, Duan, Erick , Alhazzani, Waleed , Duprey, Matthew S. , Armstrong, David , Thabane, Lehana , Tsang, Jennifer , Jaeschke, Roman , Hamielec, Cindy, Karachi, Tim , Cartin‐Ceba, Rodrigo , Cook, Deborah J, Mbuagbaw, Lawrence , Tsang, Jennifer L Y , Alshahrani, Mohammed Saeed Saad , Thabane, Lehana , Sullivan, Kristen, Devlin, John W. , Moayyedi, Paul , Muscedere, John , Cook, Deborah J, Armstrong, David

Mayo Clinic

BMJ Open | June 27, 2019 | Volume: 9 | Issue: 6 | Pages: e028237

10.1136/bmjopen-2018-028237 | PMID 31248929 Get It

Introduction Diarrhoea is a frequent concern in the intensive care unit (ICU) and is associated with prolonged mechanical ventilation, increased length of ICU stay, skin breakdown and renal dysfunction. However, its prevalence, aetiology and prognosis in the critically ill have been poorly studied. The primary objectives of this study are to determine the incidence, risk factors and consequences of diarrhoea in critically ill adults. The secondary objectives are to estimate the incidence of Clostridium difficile- associated diarrhoea (CDAD) in ICU patients and to validate the Bristol Stool Chart and Bliss Stool Classification System characterising bowel movements in the ICU. Our primary outcome is the incidence of diarrhoea . Our secondary outcomes include: CDAD, ICU and hospital mortality and ICU and hospital length of stay. Methods and analysis This international prospective cohort study will enrol patients over 10 weeks in 12 ICUs in Canada, the USA, Poland and Saudi Arabia. We will include all patients 18 years of age and older who are admitted to the ICU for at least 24 hours and follow them daily until ICU discharge. Our primary outcome is the incidence of diarrhoea based on the WHO definition, during the ICU stay. Our secondary outcomes include: CDAD, ICU and hospital mortality and ICU and hospital length of stay. We will use logistic regression to identify factors associated with diarrhoea (as defined using WHO criteria) and the kappa statistic to measure agreement on diarrhoea rates between the WHO definition and the Bristol Stool Chart and Bliss Stool Classification System. Ethics and dissemination The protocol has been approved by the research ethics board of all participating centres. The diarrhoea interventions, consequences and epidemiology in the intensive care unit (DICE-ICU) study will generate evidence about diarrhoea and its frequency, predisposing factors and consequences, to inform critical care practice and future research. Lay summary Diarrhoea is a frequent clinical problem for hospitalised patients including those who are critically ill in the ICU. Diarrhoea can cause complications such as skin damage, dehydration and kidney problems. It is not clear how common diarrhoea is in the ICU, the factors that cause it or the best way for clinicians to assess it. The DICE-ICU study is an international prospective observational study to examine the frequency, risk factors and outcomes of diarrhoea during critical illness.
Improving the patient experience through provider communication skills building
Kennedy, Denise M. , Fasolino, John P., Gullen, David

Mayo Clinic

Patient Experience Journal | June 27, 2019 | Volume: 1 | Issue: 1 | Pages: 56-60

10.35680/2372-0247.1009 Get It

The doctor’s interpersonal skills are arguably the most important to clinical outcome and patient experience. A peer-facilitated, communication skills-building course for physicians has been provided twice annually since its inception in 2004. The course was designed to increase personal awareness, as well as to help physicians develop new communication and interpersonal skills. Satisfaction data from 3,561 patient surveys on 80 providers who attended the course between 2006 and 2010 were analyzed one year before and one year after course participation. After completing the course, the proportion of “excellent” ratings of provider service (the highest rating on a 5-point scale) increased by 2% to 5.6%. The most notable improvements in service attributes under the provider’s control and covered in the course content were: involving the patient in care decisions (P < .001), explaining medical condition (P=.002), and the provider’s knowing the patient as a person (P = .004). Other improvements were noted in courtesy (by 3.4%, P=.027), listening (by 3.5%, P=.036), and overall quality of care from the provider (by 3.5%, P=.027). Attributes not directly under the provider’s control – nursing quality, teamwork, spending enough time, and likelihood to recommend – were included in the analysis; year-over-year changes in these were not significant. Further, providers who participated in the course, when compared to those who did not, experienced an 18-percent decrease in patient complaints. Improvements in perception of excellent provider communication and other service-related behaviors suggest this training approach may be useful in improving patient satisfaction, patient experience, and payment in value-based models.
Creating and sustaining a culture of accountability for patient experience
Kennedy, Denise M. , Didehban, Roshanak, Fasolino, John P., Didehban, Roshanak

Mayo Clinic

Patient Experience Journal | June 27, 2019 | Volume: 1 | Issue: 2 | Pages: 46-52

10.35680/2372-0247.1040 Get It

Improving the quality of the patient experience has become an imperative for healthcare organizations. Value-based payment models include patient perception data, and a negative experience can impact an organization’s finances. Sustainable improvement requires more than quick-fix cosmetic enhancements, ‘flavor-of-the-month’ service trainings, or bonuses for front-line staff. Organizations must actually improve the patient experience. Doing so requires a culture of accountability and a systematic framework for collecting and acting on patient perception data. This article revisits Mayo Clinic Arizona's (MCA) "7-prong" model for improving service quality: (1) multiple data sources to drive improvement; (2) accountability; (3) service consultation and improvement tools; (4) service values and behaviors; (5) education and training; (6) ongoing monitoring and control; and (7) recognition and reward. The focus of this article is Prong 2, creating and sustaining a culture of accountability for acting on service quality data to improve the patient experience. The model has demonstrated efficacy in specialty and primary care areas. Based on our experience since the model’s publication six years ago, we still contend that a comprehensive approach to improvement produces the best results. We have fine-tuned our approaches to leadership engagement, data transparency, reporting and accountability processes to ensure action on the data, and leveraging the committee structure and front-line staff. To help other organizations on their patient experience journey, we share the methodologies, tools and resources used to create and advance the culture of accountability for patient experience at MCA
Creating and integrating a new patient experience leadership role: A consultative approach for partnering with executive and clinical leaders
Kennedy, Denise M.

Mayo Clinic

Patient Experience Journal | June 27, 2019 | Volume: 2 | Issue: 1 | Pages: 155-159

10.35680/2372-0247.1074 Get It

Many healthcare organizations are creating new leadership roles to add subject matter expertise and structure to their patient experience improvement efforts. The patient experience field is emerging, however, so there are many questions about this role’s function and how best to structure it in the organization for maximal effectiveness. This article explores the benefits of a consultative approach for improving the patient experience. Previous research on management consulting and the integration of new roles in established organizations is briefly reviewed. Mayo Clinic Arizona’s (MCA) comprehensive, "7-prong" service model is revisited. Developed and implemented in 2008, the model is predicated on consultative relationships with executive and clinical leaders, is driven by data and accountability, and has demonstrated efficacy in improving the patient experience in specialty and primary care settings. Seven widely accepted service quality principles comprise the model: (1) multiple data sources to drive improvement; (2) accountability for service quality; (3) service consultation and improvement tools; (4) service values and behaviors; (5) education and training; (6) ongoing monitoring and control; and (7) recognition and reward. The focus of this article is Prong 3, service consultation. MCA’s consultative approach to structuring the patient experience leader is discussed, responsibilities are defined, qualifications are suggested, and key affiliations for integrating this new leadership role are proposed.